跳至主要内容
临床试验/NCT05391893
NCT05391893已完成4 期

Emergency Department Atrial Fibrillation Oral Diltiazem Observation Protocol

Spectrum Health - Lakeland1 个研究点 分布在 1 个国家目标入组 444 人开始时间: 2020年6月19日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
444
试验地点
1
主要终点
Admission Rate

研究概览

简要总结

The primary objective of the study is to reduce hospital admission and decrease time to disposition through establishing an effective treatment protocol for AF and Atrial Flutter in the Emergency Department of Spectrum Health Lakeland. Secondary outcome is to measure if oral diltiazem is an effective HR controlling agent in AF RVR and Flutter.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Heart rate >125
  • Systolic BP>110
  • Atrial Fibrillation/Flutter confirmed on ECG.
  • Meets observation unit requirements (performs certain ADL's (acts of daily living)

排除标准

  • Wolf-Parkinson-White syndrome
  • ST Elevation Myocardial Infarction
  • Clinical diagnosis of Sepsis,
  • Decompensated HF
  • allergy to Diltiazem
  • provider discretion
  • clinical need for cardioversion

研究组 & 干预措施

Diltiazem with oral and intravenous treatment

Active Comparator

Diltiazem 0.25mg/kg injection, give over 2 minutes, max dose 30mg. 15 minutes following Diltiazem Infusion administer oral Diltiazem 60mg IR Tablet, do not give if BP<100

干预措施: Oral (Drug)

traditional atrial fibrillation with rapid ventricular response

Placebo Comparator

these patients will receive traditional treatments at provider discretion. To be included in teh study their initial heart rate must also be over 125, and they must receive at least one intravenous medication for atrial fibrillation with rapid ventricular response. This will be a heterogenous group of patients receiving digoxin, amiodarone, various beta-blockers, and intravenous diltiazem without oral diltiazem.

干预措施: Intravenous drug (Drug)

结局指标

主要结局

Admission Rate

时间窗: 1 days

This will compare rates of patients admitted between the protocol group and patients treated traditionally

Treatment Success at 3 Hours

时间窗: 3 hours

This will compare the total number of patients who in 3 hours from first medicine administration achieved heart rate less than 110 between the protocol and traditional treatment group

次要结局

  • Rate of Hypotension(1 day)

研究者

发起方
Spectrum Health - Lakeland
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验